|
Orthologous residues
|
|
STAT1 (human): S727‑p, STAT1 (mouse): S727‑p, STAT1 (rat): S727‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
Jurkat (T lymphocyte), T lymphocyte-blood
|
|
Cellular systems studied:
cell lines, primary cells
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
anti-CD3
|
|
|
|
increase
|
|
|
PP1
|
anti-CD3
|
|
|
inhibit treatment-induced increase
|
|
|
PD98059
|
anti-CD3
|
|
|
no effect upon treatment-induced increase
|
|
|
U0126
|
anti-CD3
|
|
|
no effect upon treatment-induced increase
|
|
|
H-7
|
anti-CD3
|
|
|
no effect upon treatment-induced increase
|
|
|
SB203580
|
anti-CD3
|
|
|
no effect upon treatment-induced increase
|
|
|
LY294002
|
anti-CD3
|
|
|
no effect upon treatment-induced increase
|
|
|
wortmannin
|
anti-CD3
|
|
|
no effect upon treatment-induced increase
|
|
|
anti-CD28
|
anti-CD3
|
|
|
no effect upon treatment-induced increase
|
|
|